𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II Trial of Pegylated Interferon-α2b in Patients with Advanced Renal Cell Carcinoma

✍ Scribed by Darren R. Feldman; G. Varuni Kondagunta; Lawrence Schwartz; Sujata Patil; Nicole Ishill; John DeLuca; Paul Russo; Robert J. Motzer

Book ID
115075963
Publisher
CIG Media Group, LP.
Year
2008
Tongue
English
Weight
126 KB
Volume
6
Category
Article
ISSN
1558-7673

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of Didemnin B in patients
Phase II trial of Didemnin B in patients with advanced renal cell carcinoma
✍ Robert Motzer; Howard Scher; Dean Bajorin; Cora Sternberg; George J. Bosl 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 115 KB

Twenty-three patients with advanced renal cell cancer were treated with Didemnin B. One partial response was achieved (5070) in 21 evaluable patients. An allergic reaction was noted in four patients including one patient with anaphylaxis. Didemnin B is not recommended in the treatment of renal cell